Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment.

× No keyword cloud information.

89 in total

1. Combined pars plana vitrectomy and Baerveldt glaucoma implant placement for refractory glaucoma.

Authors: Thalmon R Campagnoli; Sung Soo Kim; William E Smiddy; Steve J Gedde; Donald L Budenz; Richard K Parrish; Paul F Palmberg; William Feuer; Wei Shi
Journal: Int J Ophthalmol Date: 2015-10-18 Impact factor: 1.779

2. Intravitreal Avastin for choroidal neovascularisation in pathological myopia: the controversy continues.

Authors: P J Rosenfeld
Journal: Br J Ophthalmol Date: 2007-02 Impact factor: 4.638

Review 3. Some ethical considerations for the "off-label" use of drugs such as Avastin.

Authors: D Wong; G Kyle
Journal: Br J Ophthalmol Date: 2006-10 Impact factor: 4.638

4. Antiproliferative and cytotoxic properties of bevacizumab on different ocular cells.

Authors: M S Spitzer; B Wallenfels-Thilo; A Sierra; E Yoeruek; S Peters; S Henke-Fahle; K U Bartz-Schmidt; P Szurman
Journal: Br J Ophthalmol Date: 2006-05-24 Impact factor: 4.638

Review 5. Anti-vascular endothelial growth factor for neovascular glaucoma.

Authors: Arathi Simha; Andrew Braganza; Lekha Abraham; Prasanna Samuel; Kristina Lindsley
Journal: Cochrane Database Syst Rev Date: 2013-10-02

Review 6. A review of anti-VEGF agents for proliferative diabetic retinopathy.

Authors: P Osaadon; X J Fagan; T Lifshitz; J Levy
Journal: Eye (Lond) Date: 2014-02-14 Impact factor: 3.775

7. Inhibitory effects of bevacizumab on angiogenesis and corneal neovascularization.

Authors: Young Sang Han; Ji Eun Lee; Ji Won Jung; Jong Soo Lee
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2008-10-25 Impact factor: 3.117

8. Panretinal photocoagulation with simultaneous cryoretinopexy or intravitreal bevacizumab for neovascular glaucoma.

Authors: Tomoaki Tatsumi; Shuichi Yamamoto; Juntaro Uehara; Takeshi Sugawara; Takayuki Baba; Masayuki Inoue; Hiroko Hata; Yoshinori Mitamura
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2012-12-19 Impact factor: 3.117

Review 9. Treatment of diabetic retinopathy: Recent advances and unresolved challenges.

Authors: Michael W Stewart
Journal: World J Diabetes Date: 2016-08-25

10. Retinal microangiopathy in a mouse model of inducible mural cell loss.

Authors: Cammi N Valdez; Joseph F Arboleda-Velasquez; Dhanesh S Amarnani; Leo A Kim; Patricia A D'Amore
Journal: Am J Pathol Date: 2014-08-01 Impact factor: 4.307